Chinese Journal of Antituberculosis ›› 2018, Vol. 40 ›› Issue (4): 425-428.doi: 10.3969/j.issn.1000-6621.2018.04.015
• Review Articles • Previous Articles Next Articles
Bing-ye LIU,De-cheng WANG(),Xiao-yong FAN(
)
Received:
2018-01-11
Online:
2018-04-10
Published:
2018-05-14
Contact:
De-cheng WANG,Xiao-yong FAN
E-mail:dcwang99@163.com;xyfan008@fudan.edu.cn
Bing-ye LIU,De-cheng WANG,Xiao-yong FAN. The role and application of cytokines interleukin-7 and interleukin-15 in tuberculosis infection[J]. Chinese Journal of Antituberculosis, 2018, 40(4): 425-428. doi: 10.3969/j.issn.1000-6621.2018.04.015
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2018.04.015
名称 | 结构与大小 | 主要合成场所 | 受体 | 功能 |
---|---|---|---|---|
IL-2 | 相对分子质量15500,133个氨基酸,四螺旋结构 | 活化的T细胞 | IL-2Rα和IL-2Rβ、γ被活化的T/B细胞共表达 | 自然杀伤细胞(NK细胞)、T细胞与B细胞的增殖和分化,消除自身反应性T细胞,介导活化诱导的细胞死亡作用和维护调节性T细胞 |
IL-7 | 相对分子质量25000,152个氨基酸,四螺旋结构 | 骨髓基质细胞和胸腺细胞 | 由IL-7Rα和IL-7Rγ组成,表达于大多数静息T细胞 | 促进前B细胞增殖;影响记忆性T细胞的存活;参与和影响调节性T细胞增殖 |
IL-15 | 相对分子质量14000~15000,114个氨基酸,四螺旋结构 | 树突状细胞、巨噬细胞和肌肉组织等 | 单核巨噬细胞和树突状细胞表面的IL-15Rα将IL-15转运到自然杀伤细胞、CD8+ T细胞,表达IL-15Rβ/γ | 参与自然杀伤细胞、T细胞及B细胞的增殖和分化,维持CD8+ 记忆性T细胞 |
[1] | World Health Organization . Global tuberculosis report 2017. Geneva:World Health Organization, 2017. |
[2] |
Grabstein KH, Eisenman J, Shanebeck K , et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science, 1994,264(5161):965-968.
doi: 10.1126/science.8178155 URL |
[3] |
Waldmann TA . The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol, 2006,6(8):595-601.
doi: 10.1038/nri1901 URL |
[4] | Ding JY, Wang ZH, Zhang ZZ , et al. Effects of three IL-15 variants on NCI-H446 cell proliferation and expression of cell cycle regulatory molecules. Oncotarget, 2017,8(64):108108-108117. |
[5] |
Kielsen K, Ryder LP, Lennox-Hvenekilde D , et al. Reconstitution of Th17, Tc17 and Treg cells after paediatric haematopoietic stem cell transplantation: Impact of interleukin-7. Immunobiology, 2018,223(2):220-226.
doi: 10.1016/j.imbio.2017.10.023 URL |
[6] |
Hou H, Kang Y, Zeng Y , et al. Interleukin-7 augments CD8 + T cells function and promotes viral clearance in chronic hepatitis C virus infection . Cytokine, 2018,102:26-33.
doi: 10.1016/j.cyto.2017.12.014 URL |
[7] |
Osinalde N, Sanchez-Quiles V, Akimov V , et al. Simultaneous dissection and comparison of IL-2 and IL-15 signaling pathways by global quantitative phosphoproteomics. Proteomics, 2015,15(2/3):520-531.
doi: 10.1002/pmic.201400194 URL |
[8] |
Shenoy AR, Kirschnek S, Häcker G . IL-15 regulates Bcl-2 family members Bim and Mcl-1 through JAK/STAT and PI3K/AKT pathways in T cells. Eur J Immunol, 2014,44(8):2500-2507.
doi: 10.1002/eji.v44.8 URL |
[9] |
Abdelsamed HA, Moustaki A, Fan Y , et al. Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis. J Exp Med, 2017,214(6):1593-1606.
doi: 10.1084/jem.20161760 URL |
[10] |
Markley JC, Sadelain M . IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood, 2010,115(17):3508-3519.
doi: 10.1182/blood-2009-09-241398 URL |
[11] |
Ishimitsu R, Nishimura H, Yajima T , et al. Overexpression of IL-15 in vivo enhances Tc1 response, which inhibits allergic inflammation in a murine model of asthma. J Immunol, 2001,166(3):1991-2001.
doi: 10.4049/jimmunol.166.3.1991 URL |
[12] | 孙源彬, 陈丽丽 . 白细胞介素-15在感染性疾病中作用的研究进展. 中国生物制品学杂志, 2016,29(4):434-437. |
[13] |
Cha E, Graham L, Manjili MH , et al. IL-7+ IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo. Breast Cancer Res Treat, 2010,122(2):359-369.
doi: 10.1007/s10549-009-0573-0 URL |
[14] | 黄健 . 肺结核患者血清中 IL-15, IL-2, IFN-γ治疗前后的变化及临床意义. 长沙:中南大学, 2014. |
[15] |
Harris SA, Meyer J, Satti I , et al. Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination. J Infect Dis, 2014,209(8):1259-1268.
doi: 10.1093/infdis/jit647 URL |
[16] |
Tang C, Yamada H, Shibata K , et al. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis. J Infect Dis, 2008,197(9):1263-1274.
doi: 10.1086/589525 URL |
[17] |
Pydi SS, Bandaru AR, Venkatasubramanian S , et al. Vaccine for tuberculosis: up-regulation of IL-15 by Ag85A and not by ESAT-6. Tuberculosis, 2011,91(2):136-139.
doi: 10.1016/j.tube.2010.12.003 URL pmid: 21212022 |
[18] |
Chandrashekara S, Anupama KR, Sambarey A , et al. High IL-6 and low IL-15 levels mark the presence of TB infection: A preliminary study. Cytokine, 2016,81:57-62.
doi: 10.1016/j.cyto.2016.02.003 URL pmid: 26878649 |
[19] |
Yeon SM, Halim L, Chandele A , et al. IL-7 plays a critical role for the homeostasis of allergen-specific memory CD4 T cells in the lung and airways. Sci Rep, 2017,7(1):11155.
doi: 10.1038/s41598-017-11492-7 URL |
[20] |
Lundtoft C, Afum-Adjei Awuah A, Rimpler J , et al. Aberrant plasma IL-7 and soluble IL-7 receptor levels indicate impaired T-cell response to IL-7 in human tuberculosis. PLoS Pathogens, 2017,13(6):e1006425.
doi: 10.1371/journal.ppat.1006425 URL |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||